15 patient evaluations for Natalizumab with a cost of $200+
127 members have decided to share their profiles only with other members of PatientsLikeMe.
Sort by:
Most recent
Jul 27, 2009 (Started Aug 31, 2006)
-
EffectivenessMajor (for multiple sclerosis)
-
Side effectsMild (tiredness)
-
AdherenceAlways
-
BurdenA little hard to take
Dosage:
300 mg/15 mL
every 4 weeks
Cost:
$200+ monthly
Side effects:
tiredness
- 0 helpful marks
Apr 15, 2009 (Started Dec 25, 2007)
-
EffectivenessModerate (for multiple sclerosis)
-
Side effectsNone
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
300 mg/15 mL
Monthly
Cost:
$200+ monthly
Dec 25, 2008 (Started Dec 25, 2007)
-
EffectivenessCan't tell (for multiple sclerosis)
-
Side effectsNone
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
300 mg/15 mL
Monthly
Cost:
$100-199 monthly
- 1 helpful mark
Aug 22, 2008 (Started Jan 04, 2008)
-
EffectivenessNone (for multiple sclerosis)
-
Side effectsMild (headaches, tiredness)
-
AdherenceAlways
-
BurdenA little hard to take
Dosage:
300 mg
Monthly
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost:
$200+ monthly
Side effects:
headaches, tiredness
- 0 helpful marks
Aug 20, 2008 (Started Oct 01, 2007)
-
EffectivenessSlight (for multiple sclerosis)
-
Side effectsMild (headaches)
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
300 mg/15 mL
Monthly
Cost:
$200+ monthly
Side effects:
headaches
- 0 helpful marks
Nov 2, 2007 (Started Aug 09, 2007)
-
EffectivenessCan't tell (for multiple sclerosis)
-
Side effectsSevere (generalized weakness (asthenia), nausea, headaches, lethargy)
-
AdherenceAlways
-
BurdenVery hard to take
Dosage:
300 mg/15 mL
Monthly
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost:
$200+ monthly
Side effects:
generalized weakness (asthenia), nausea, headaches, lethargy
- 2 helpful marks
Last updated:
Showing 5 of 15 patient evaluations for Natalizumab